Quantitative Pharmacoepidemiologist

At AstraZeneca, we pride ourselves on crafting a collaborative culture that champions knowledge-sharing, ambitious thinking and innovation – ultimately providing employees with the opportunity to work across teams, functions and even the globe.

Recognizing the importance of individualized flexibility, our ways of working allow employees to balance personal and work commitments while ensuring we continue to create a strong culture of collaboration and teamwork by engaging face-to-face in our offices 3 days a week. Our head office and in downtown Toronto are purposely designed with collaboration in mind, providing space where teams can come together to strategize, brainstorm and connect on key projects.

Our dedication to sustainability is also central to our culture and part of what makes AstraZeneca a great place to work. We know the health of people, the planet and our business are interconnected which is why we’re taking ambitious action to tackle some of the biggest challenges of our time, from climate change to access to healthcare and disease prevention.

AstraZeneca’s Safety Epidemiology team is a global group of PhD-trained pharmacoepidemiologists with expertise in conducting epidemiological studies, performing evidence synthesis and analytics to evaluate drug safety. The team plans and delivers R&D safety epidemiology activities that inform the benefit–risk profiles of nearly 100 marketed and pipeline products. These activities include local and global post-authorisation regulatory commitment studies (PARCS) submitted to health authorities such as the FDA and EMA.

Safety Epidemiology offers a dynamic, inclusive and supportive environment where epidemiologists can build rewarding careers and make meaningful contributions to drug development, pharmacoepidemiology and public health. We welcome applications from recent PhD graduates and postdoctoral researchers in epidemiology who are interested in drug safety, real-world data analysis and a career in the pharmaceutical industry.

The quantitative pharmacoepidemiologist role will report to the Senior Director, Safety Epidemiology and is a pivotal scientific role within Global Patient Safety, accountable for performing rapid analyses of large electronic healthcare databases from around the world to support PARCS planning, signal detection, predictive clinical safety, clinical trial planning, drug development, new drug applications to regulatory authorities and to support responses to health authorities (e.g., FDA , EMA etc).

The incumbent will be responsible for delivering high-quality descriptive epidemiological analyses of real-world healthcare data across various products in the AZ portfolio. The role applies analytical methods to generate robust evidence from electronic healthcare databases and collaborates with multidisciplinary teams to address scientific and business questions. Key responsibilities include programmatic specification of a research question, analytical study execution, data interpretation, programming, evidence generation, and communication of findings to internal collaborators across Global Patient Safety, Global Regulatory, Global Medical/Clinical functions.

• Ph.D. in pharmacoepidemiology, epidemiology, public health, biostatistics or related health science field and substantial hands‑on experience analysing large electronic healthcare data (relational databases) and other real world data sources (claims, registry or other secondary healthcare databases)
• Advanced level skills in syntax‑based SAS or R
• A strong interest in pursuing a career in pharmacoepidemiology and drug safety
• Able to apply epidemiological theory and techniques to solve new and challenging problems
• Conceptual understanding of…